Arbutus Biopharma Corp. buy BiotechBee
Start price
08.09.24
/
60%
€4.21
Target price
31.03.27
€7.00
Performance (%)
-18.27%
End price
14.12.24
€3.44
Summary
This prediction ended on 14.12.24 with a price of €3.44. The prediction for Arbutus Biopharma Corp. disappointed with a performance of -18.27%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arbutus Biopharma Corp. | -1.963% | -1.963% | 23.257% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
According to BiotechBee what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year